Cargando…

Retrospective analysis of a dedicated care pathway for nonalcoholic fatty liver disease in an integrated US healthcare system demonstrates support of weight management and improved ALT

BACKGROUND: A care pathway for nonalcoholic fatty liver disease (NAFLD) in Kaiser Permanente San Diego, California was instituted in August 2017 to improve efficiency of disease staging and promote lifestyle modification. METHODS: The NAFLD Care Pathway includes: (1) patient education (2) vibration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patton, Heather, Burchette, Raoul, Tovar, Stephanie, Pio, Jose, Shi, Jiaxiao, Nyberg, Lisa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603663/ https://www.ncbi.nlm.nih.gov/pubmed/33129272 http://dx.doi.org/10.1186/s12876-020-01492-9

Ejemplares similares

Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
por: Fallatah, Hind I., et al.
Publicado: (2016)

Racial Differences in Nonalcoholic Fatty Liver Disease in the U.S. Population
por: Schneider, Andrea L. C., et al.
Publicado: (2013)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature
por: Almanza, Diego, et al.
Publicado: (2018)

The Effect of Weight Reduction on Ultrasonographic Findings of Nonalcoholic Fatty Liver
por: Tahaei, SA, et al.
Publicado: (2010)

The Effect of Weight Loss on Pediatric Nonalcoholic Fatty Liver Disease
por: St-Jules, David E., et al.
Publicado: (2013)

The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight
por: Cho, Ji-Young, et al.
Publicado: (2014)

Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease
por: Slowik, Voytek, et al.
Publicado: (2020)

How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease?
por: Ghaemi, Alireza, et al.
Publicado: (2013)

Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
por: Jung, Inha, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

A285 CHANGE IN ALT DURING MODIFIED OPTIFAST WEIGHT LOSS PROGRAM IN INDIVIDUALS AT RISK FOR NON-ALCOHOLIC FATTY LIVER DISEASE
por: Meddings Maybury, L, et al.
Publicado: (2023)

Galerie Alte Meister /
Publicado: (1979)

Alte nationalgalerie Berlin

Ctrl alt share
Publicado: (2015)

The Alt-Scherbitz Asylum
Publicado: (1898)

Alt HealthWatch
por: Christianson, Merete
Publicado: (2017)

Dedication: Spotlight on moral injury and repair in healthcare
por: Pico, Elaine L.
Publicado: (2023)

Effects of BRCA2 deficiency on telomere recombination in non-ALT and ALT cells
por: Sapir, Ester, et al.
Publicado: (2011)

G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells
por: Amato, Roberta, et al.
Publicado: (2020)

Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss
por: Popov, Violeta B., et al.
Publicado: (2015)

Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver disease
por: Lian, Kun, et al.
Publicado: (2019)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
por: Kim, Mi Na, et al.
Publicado: (2021)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Serum iron and risk of nonalcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Yang, Huan-Huan, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea
por: Nah, Eun-Hee, et al.
Publicado: (2022)

Long-term weight changes are associated with initial weight changes after nonalcoholic fatty liver disease diagnosis
por: DiBattista, Jacob V., et al.
Publicado: (2023)

Dedicated to the Late Professor Jae-Duk Lew
por: Tark, Kwan Chul, et al.
Publicado: (2023)

Arthroscopic surgery for global versus focal pincer femoroacetabular impingement: are the outcomes different?
por: Matsuda, Dean K., et al.
Publicado: (2015)

Nuclear envelope tethering inhibits the formation of ALT-associated PML bodies in ALT cells
por: Yang, Chia-Wei, et al.
Publicado: (2021)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Body weight gain rather than body weight variability is associated with increased risk of nonalcoholic fatty liver disease
por: Cho, Eun Ju, et al.
Publicado: (2021)

Astrofisica delle alte energie
por: Vietri, Mario
Publicado: (2006)

Telomere clustering drives ALT
por: Min, Jaewon, et al.
Publicado: (2019)

The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease
por: Karandish, Majid, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f2133jlb2kdpjr1jnf9t1ob80p